Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Tolerability of SYN006 HFA MDI in Healthy Volunteers
NCT02165033Phase 1Completed
- Sponsor
- Intech Biopharm Corporation
- Start
- Nov 2012
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of budesonide and procaterol in asthma, sponsored by Intech Biopharm Corporation. Primary endpoints: Area Under Curve at Day 7, Peak Plasma Concentration at Day 7 and 1 more. Started Nov 2012; status: completed.
02
Drugs
budesonideprocaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02165033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02165033.